Evidence map›Paper›PMID 29336013›Full record

SynthesisThe British journal of dermatology2018

Systematic review of atopic dermatitis disease definition in studies using routinely collected health data.

M P Dizon, A M Yu, R K Singh, J Wan, M-M Chren, C Flohr, J I Silverberg, D J Margolis, S M Langan, K Abuabara

Open access · bronzeAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The British journal of dermatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Fruit vinegar as a promising source of natural anti-inflammatory agents: an up-to-date review.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 3 countries.

M P DizonProgram for Clinical Research, Department of Dermatology, University of California, San Francisco School of Medicine, San Francisco, CA, U.S.A.
A M YuFaculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
R K SinghUniversity of California, Los Angeles, David Geffen School of Medicine at UCLA, Los Angeles, CA, U.S.A.
J WanDepartment of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, U.S.A.
M-M ChrenDepartment of Dermatology, Vanderbilt University Medical Center, Nashville, TN 37204, U.S.A.
C FlohrUnit for Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's & St Thomas' NHS Foundation Trust and King's College London, Chicago, IL, U.S.A.ORCID 0000-0003-4884-6286
J I SilverbergDepartments of Dermatology, Preventive Medicine and Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, U.S.A.ORCID 0000-0003-3686-7805
D J MargolisDepartment of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, U.S.A.
S M LanganFaculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, U.K.
K AbuabaraProgram for Clinical Research, Department of Dermatology, University of California, San Francisco School of Medicine, San Francisco, CA, U.S.A.ORCID 0000-0002-7736-6946
University of California, San Francisco · USUniversity of Pennsylvania · USGuy's and St Thomas' NHS Foundation Trust · GBLondon School of Hygiene & Tropical Medicine · GBNorthwestern University · USUniversity of California, Los Angeles · USUniversity of Ottawa · CAVanderbilt University Medical Center · US

Funding

Institutional Career Development Core SupplementKL2TR001870 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KANAYA, ALKA M., SARKAR, URMIMALA · 2016 to 2025
$19.7M
Penn Dermatology Research Training ProgramT32AR007465 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI Elizabeth Anne Grice, David Joel Margolis · 1986 to 2026
$9.0M
AHRQ HHS K12 HS023011Department of Health NIHR/CS/010/014NCATS NIH HHS KL2 TR001870NIAMS NIH HHS T32 AR007465Wellcome Trust 205039/Z/16/Z
6 · The paper itself

Abstract

backgroundRoutinely collected electronic health data obtained for administrative and clinical purposes are increasingly used to study atopic dermatitis (AD). Methods for identifying AD patients in routinely collected electronic health data differ, and it is unknown how this might affect study results.

objectivesTo evaluate how patients with AD have been identified in studies using routinely collected electronic health data, to determine whether these methods were validated and to estimate how the method for identifying patients with AD affected variability in prevalence estimates.

methodsWe systematically searched PubMed, Embase and Web of Science for studies using routinely collected electronic health data that reported on AD as a primary outcome. Studies of localized AD and other types of dermatitis were excluded. The protocol for this review was registered in PROSPERO (CRD42016037968).

resultsIn total, 59 studies met eligibility criteria. Medical diagnosis codes for inclusion and exclusion, number of occasions of a code, type of provider associated with a code and prescription data were used to identify patients with AD. Only two studies described validation of their methods and no study reported on disease severity. Prevalence estimates ranged from 0·18% to 38·33% (median 4·91%) and up to threefold variation in prevalence was introduced by differences in the method for identifying patients with AD.

conclusionsThis systematic review highlights the need for clear reporting of methods for identifying patients with AD in routinely collected electronic health data to allow for meaningful interpretation and comparison of results.

Indexed as

AdultAlgorithmsChildClinical CodingData CollectionDermatitis, AtopicElectronic Health RecordsFemaleHumansMalePrevalenceTerminology as Topic

Identifiers

PMID29336013
PMCPMC6033033
OpenAlexW2783361657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.